Certain Sleep-Disordered Breathing Treatment Mask Systems and Components Thereof; Notice of the Commission's Determination To Review an Initial Determination Amending the Complaint and Notice of Investigation; Affirmance of the Initial Determination With Modified Reasoning, 8544-8545 [2019-04243]
Download as PDF
<![CDATA[
8544
Federal Register / Vol. 84, No. 46 / Friday, March 8, 2019 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–929–931 (Third
Review)]
Silicomanganese From India,
Kazakhstan, and Venezuela;
Scheduling of Expedited Five-Year
Reviews
United States International
Trade Commission.
ACTION: Notice.
AGENCY:
The Commission hereby gives
notice of the scheduling of expedited
reviews pursuant to the Tariff Act of
1930 (‘‘the Act’’) to determine whether
revocation of the antidumping duty
orders on silicomanganese from India,
Kazakhstan, and Venezuela would be
likely to lead to continuation or
recurrence of material injury within a
reasonably foreseeable time.
DATES: December 10, 2018.
FOR FURTHER INFORMATION CONTACT:
Christopher W. Robinson, (202–202–
2542), Office of Investigations, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436.
Hearing-impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
these reviews may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.—On December 10, 2018,
the Commission determined that the
domestic interested party group
response to its notice of institution (83
FR 44898, September 4, 2018) of the
subject five-year reviews was adequate
and that the respondent interested party
group response was inadequate in each
review. The Commission did not find
any other circumstances that would
warrant conducting full reviews.1
Accordingly, the Commission
determined that it would conduct
expedited reviews pursuant to section
751(c)(3) of the Tariff Act of 1930 (19
U.S.C. 1675(c)(3)).2 Due to the lapse in
SUMMARY:
1 A record of the Commissioners’ votes, the
Commission’s statement on adequacy, and any
individual Commissioner’s statements will be
available from the Office of the Secretary and at the
Commission’s website.
2 Chairman Johanson and Commissioner
Broadbent voted to conduct full reviews.
VerDate Sep<11>2014
16:24 Mar 07, 2019
Jkt 247001
appropriations and ensuing cessation of
Commission operations, the
Commission tolled its deadlines in these
reviews.
For further information concerning
the conduct of these reviews and rules
of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
Staff report.—A staff report
containing information concerning the
subject matter of the reviews will be
placed in the nonpublic record on
March 7, 2019, and made available to
persons on the Administrative
Protective Order service list for these
reviews. A public version will be issued
thereafter, pursuant to section
207.62(d)(4) of the Commission’s rules.
Written submissions.—As provided in
section 207.62(d) of the Commission’s
rules, interested parties that are parties
to the reviews and that have provided
individually adequate responses to the
notice of institution, and any party other
than an interested party to the reviews
may file written comments with the
Secretary on what determinations the
Commission should reach in the
reviews. Comments are due on or before
March 12, 2019 and may not contain
new factual information. Any person
that is neither a party to the five-year
reviews nor an interested party may
submit a brief written statement (which
shall not contain any new factual
information) pertinent to the reviews by
March 12, 2019. However, should the
Department of Commerce (‘‘Commerce’’)
extend the time limit for its completion
of the final results of its reviews, the
deadline for comments (which may not
contain new factual information) on
Commerce’s final results is three
business days after the issuance of
Commerce’s results. If comments
contain business proprietary
information (BPI), they must conform
with the requirements of sections 201.6,
207.3, and 207.7 of the Commission’s
rules. The Commission’s rules with
respect to filing were revised effective
July 25, 2014. See 79 FR 35920 (June 25,
2014), and the revised Commission
Handbook on E-filing, available from the
Commission’s website at https://
edis.usitc.gov.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the reviews must be
served on all other parties to the reviews
(as identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Determinations.—The Commission
has determined these reviews are
extraordinarily complicated and
therefore has determined to exercise its
authority to extend the reviews period
by up to 90 days pursuant to 19 U.S.C.
1675(c)(5)(B).
Authority: These reviews are being
conducted under authority of title VII of
the Tariff Act of 1930; this notice is
published pursuant to section 207.62 of
the Commission’s rules.
By order of the Commission.
Issued: March 4, 2019.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2019–04170 Filed 3–7–19; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1134]
Certain Sleep-Disordered Breathing
Treatment Mask Systems and
Components Thereof; Notice of the
Commission’s Determination To
Review an Initial Determination
Amending the Complaint and Notice of
Investigation; Affirmance of the Initial
Determination With Modified
Reasoning
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined to review
the presiding administrative law judge’s
(‘‘ALJ’’) initial determination (‘‘ID’’)
(Order No. 11) amending the complaint
and notice of investigation to reflect a
corporate name change of complainant
ResMed Ltd to ResMed Pty Ltd.
FOR FURTHER INFORMATION CONTACT:
Amanda Pitcher Fisherow, Esq., Office
of the General Counsel, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436,
telephone (202) 205–2737. Copies of
non-confidential documents filed in
connection with this investigation are or
will be available for inspection during
official business hours (8:45 a.m. to 5:15
p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
SUMMARY:
E:\FR\FM\08MRN1.SGM
08MRN1
Federal Register / Vol. 84, No. 46 / Friday, March 8, 2019 / Notices
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on October 4, 2018, based on a
complaint, as supplemented, filed on
behalf of ResMed Corp. of San Diego,
California, ResMed Inc. of San Diego,
California, and ResMed Ltd. of Bella
Vista, Australia (collectively,
‘‘Complainants’’). 83 FR 50,121 (October
4, 2018). The complaint, as
supplemented, alleges violations of
Section 337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337 (‘‘section
337’’), based upon the importation into
the United States, the sale for
importation, and the sale within the
United States after importation of
certain sleep-disordered breathing
treatment mask systems and
components thereof by reason of
infringement of certain claims of U.S.
Patent No. 9,119,931; U.S. Patent No.
9,027,556; U.S. Patent No. 9,962,511;
U.S. Patent No. 9,962,510; U.S. Patent
No. 9,937,315. The complaint further
alleges that an industry in the United
States exists as required by section 337.
The notice of investigation named
Fisher & Paykel Healthcare Limited of
Auckland, New Zealand; Fisher &
Paykel Healthcare, Inc. of Irvine,
California; and Fisher & Paykel
Healthcare Distribution Inc. of Irvine,
California as respondents. The Office of
Unfair Import Investigations is not
participating in this investigation.
On February 13, 2019, the
Complainants filed an unopposed
motion for leave to amend the
complaint and notice of investigation to
reflect a corporate name change of one
of the complainants from ResMed Ltd to
ResMed Pty Ltd. Complainants argued
that good cause exists and that there
would be no harm to the public interest.
On February 14, 2019, the ALJ issued
the subject ID, granting complainants’
unopposed motion. The ID found that
good cause exists to amend the
complaint and notice of investigation.
The ID also noted that there was no
opposition to the motion. No petitions
for review were filed.
The Commission has determined to
review the ID. On review, the
Commission affirms the ID’s finding that
good cause has been shown. The
Commission further finds that the
amendment to the notice of
investigation and complaint would not
prejudice the public interest. The
VerDate Sep<11>2014
16:24 Mar 07, 2019
Jkt 247001
complaint and notice of investigation
are amended to reflect the corporate
name change from ResMed Ltd to
ResMed Pty Ltd.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: March 5, 2019.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2019–04243 Filed 3–7–19; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Petroleum Environmental
Research Forum
Notice is hereby given that, on
February 22, 2019, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Petroleum Environmental Research
Forum (‘‘PERF’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, CH2MHill, Englewood, CO;
GeoSyntec Consultants, Inc., Boca
Raton, FL; Syncrude Canada, Ltd.,
Edmonton, CANADA; Test America,
Inc., Parker, CO; Nalco, Sugar Land, TX;
and Trihydro, Laramie, WY, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and PERF intends
to file additional written notifications
disclosing all changes in membership.
On February 10, 1986, PERF filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on March 14, 1986 (51 FR 8903).
The last notification was filed with
the Department on January 29, 1019. A
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
8545
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 14, 2019 (84 FR 4103).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–04193 Filed 3–7–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Halon Alternatives
Research Corporation, Inc.
Notice is hereby given that, on
February 21, 2019, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), Halon
Alternatives Research Corporation, Inc.
(‘‘HARC’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Airbus S.A.S.1, Toulouse,
FRANCE and Honeywell, Morris Plains,
NJ, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and HARC
intends to file additional written
notifications disclosing all changes in
membership.
On February 7, 1990, HARC filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on March 7, 1990 (55 FR 8204).
The last notification was filed with
the Department on March 9, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on April 10, 2017 (82 FR 17281).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–04195 Filed 3–7–19; 8:45 am]
BILLING CODE 4410–11–P
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 84, Number 46 (Friday, March 8, 2019)]
[Notices]
[Pages 8544-8545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04243]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1134]
Certain Sleep-Disordered Breathing Treatment Mask Systems and
Components Thereof; Notice of the Commission's Determination To Review
an Initial Determination Amending the Complaint and Notice of
Investigation; Affirmance of the Initial Determination With Modified
Reasoning
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined to review the presiding administrative law
judge's (``ALJ'') initial determination (``ID'') (Order No. 11)
amending the complaint and notice of investigation to reflect a
corporate name change of complainant ResMed Ltd to ResMed Pty Ltd.
FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office
of the General Counsel, U.S. International Trade Commission, 500 E
Street SW, Washington, DC 20436, telephone (202) 205-2737. Copies of
non-confidential documents filed in connection with this investigation
are or will be available for inspection during official business hours
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW, Washington, DC 20436,
telephone (202) 205-2000. General information concerning the Commission
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov.
Hearing-impaired
[[Page 8545]]
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on October 4, 2018, based on a complaint, as supplemented, filed on
behalf of ResMed Corp. of San Diego, California, ResMed Inc. of San
Diego, California, and ResMed Ltd. of Bella Vista, Australia
(collectively, ``Complainants''). 83 FR 50,121 (October 4, 2018). The
complaint, as supplemented, alleges violations of Section 337 of the
Tariff Act of 1930, as amended, 19 U.S.C. 1337 (``section 337''), based
upon the importation into the United States, the sale for importation,
and the sale within the United States after importation of certain
sleep-disordered breathing treatment mask systems and components
thereof by reason of infringement of certain claims of U.S. Patent No.
9,119,931; U.S. Patent No. 9,027,556; U.S. Patent No. 9,962,511; U.S.
Patent No. 9,962,510; U.S. Patent No. 9,937,315. The complaint further
alleges that an industry in the United States exists as required by
section 337. The notice of investigation named Fisher & Paykel
Healthcare Limited of Auckland, New Zealand; Fisher & Paykel
Healthcare, Inc. of Irvine, California; and Fisher & Paykel Healthcare
Distribution Inc. of Irvine, California as respondents. The Office of
Unfair Import Investigations is not participating in this
investigation.
On February 13, 2019, the Complainants filed an unopposed motion
for leave to amend the complaint and notice of investigation to reflect
a corporate name change of one of the complainants from ResMed Ltd to
ResMed Pty Ltd. Complainants argued that good cause exists and that
there would be no harm to the public interest.
On February 14, 2019, the ALJ issued the subject ID, granting
complainants' unopposed motion. The ID found that good cause exists to
amend the complaint and notice of investigation. The ID also noted that
there was no opposition to the motion. No petitions for review were
filed.
The Commission has determined to review the ID. On review, the
Commission affirms the ID's finding that good cause has been shown. The
Commission further finds that the amendment to the notice of
investigation and complaint would not prejudice the public interest.
The complaint and notice of investigation are amended to reflect the
corporate name change from ResMed Ltd to ResMed Pty Ltd.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
By order of the Commission.
Issued: March 5, 2019.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2019-04243 Filed 3-7-19; 8:45 am]
BILLING CODE 7020-02-P
